Shionogi/Merck HIV Patent Tussle Set To Go Another Round

Shionogi has vowed to appeal a ruling by a court in the UK that a patent relating to HIV integrase inhibitors is invalid, as an ongoing European intellectual property tussle with rival Merck & Co gathers steam.